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ABSTRACT

Musculoskeletal infections are infections of the bone and surrounding
tissues. They are currently diagnosed based on culture analysis, which is the gold
standard for pathogen identification. However, these clinical laboratory methods are
frequently inadequate for the identification of the causative agents, because a large
percentage (25-50%) of confirmed musculoskeletal infections are false negatives in
which no pathogen is identified in culture. My data supports these results. The goal
of this project was to use PCR amplification of a portion of the 16S rRNA gene to
test an alternative approach for the identification of these pathogens and to assess
the diversity of the bacteria involved. The advantages of this alternative method are
that it should increase sample sensitivity and the speed of detection. In addition,
bacteria that are non-culturable or in low abundance can be detected using this
molecular technique. However, a complication of this approach is that the majority
of musculoskeletal infections are polymicrobial, which prohibits direct identification
from the infected tissue by DNA sequencing of the initial 16S rDNA amplification
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products. One way to solve this problem is to use denaturing gradient gel
electrophoresis (DGGE) to separate the PCR products before DNA sequencing.
Denaturing gradient gel electrophoresis (DGGE) separates DNA molecules
based on their melting point, which is determined by their DNA sequence. This
analytical technique allows a mixture of PCR products of the same length that
electrophoreses through agarose gels as one band, to be separated into different
bands and then used for DNA sequence analysis. In this way, the DGGE allows for
the identification of individual bacterial species in polymicrobial-infected tissue,
which is critical for improving clinical outcomes. By combining the 16S rDNA
amplification and the DGGE techniques together, an alternative approach for
identification has been used.
The 16S rRNA gene PCR-DGGE method includes several critical steps: DNA
extraction from tissue biopsies, amplification of the bacterial DNA, PCR product
separation by DGGE, amplification of the gel-extracted DNA, and DNA sequencing
and analysis. Each step of the method was optimized to increase its sensitivity and
for rapid detection of the bacteria present in human tissue samples. The limit of
detection for the DNA extraction from tissue was at least 20 Staphylococcus aureus
cells and the limit of detection for PCR was at least 0.05 pg of template DNA. The
conditions for DGGE electrophoreses were optimized by using a double gradient of
acrylamide (6 – 10%) and denaturant (30-70%), which increased the separation
between distinct PCR products. The use of GelRed (Biotium) improved the DNA
visualization in the DGGE gel. To recover the DNA from the DGGE gels the gel
slices were excised, shredded in a bead beater, and the DNA was allowed to diffuse
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into sterile water overnight. The use of primers containing specific linkers allowed
the entire amplified PCR product to be sequenced and then analyzed.
The optimized 16S rRNA gene PCR-DGGE method was used to analyze 50
tissue biopsy samples chosen randomly from our collection. The results were
compared to those of the Memorial Hermann Hospital Clinical Microbiology
Laboratory for the same samples. The molecular method was congruent for 10 of
the 17 (59%) culture negative tissue samples. In 7 of the 17 (41%) culture negative
the molecular method identified a bacterium. The molecular method was congruent
with the culture identification for 7 of the 33 (21%) positive cultured tissue samples.
However, in 8 of the 33 (24%) the molecular method identified more organisms. In
13 of the 15 (87%) polymicrobial cultured tissue samples the molecular method
identified at least one organism that was also identified by culture techniques.
Overall, the DGGE analysis of 16S rDNA is an effective method to identify bacteria
not identified by culture analysis.
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INTRODUCTION

Musculoskeletal Infections
Musculoskeletal infections can be defined as infections of the bone and
surrounding tissues (29). These infections include various medical conditions:
osteomyelitis (bone infection), septic arthritis (infection of the synovial membrane of
joints), and pyomyositis (skeletal muscle infections) (11, 29). Generally, a
physician’s initial diagnosis of a musculoskeletal infection is based on the presence
of typical clinical symptoms, which may include high fever, malaise, localized pain,
inflammation, pus and loss of function of the involved extremity. In cases of arthritis,
swelling of the affected joint may develop (11, 21). A rapid diagnosis of
musculoskeletal infections is important to prevent complications and aid in the
recovery. The physician’s diagnosis should be confirmed by culture analysis, which
is the gold standard for pathogen identification (46, 47). A bone or tissue biopsy of
the infected area or aspiration of the joint fluid are the samples most likely to give a
positive culture (17). However, the current clinical laboratory methods are frequently
inadequate for the identification of the causative agents. Recent case reviews and
my own data, identify a large percentage (25-50%) of confirmed musculoskeletal
infections for which no pathogen is identified in culture (17, 47). It has been stated
that for osteomyelitis cases, “the most important step is to isolate the offending
organisms so that the appropriate therapy can be chosen” (27). A possible solution
to decreasing the number of false negative cultures is to use a method that does not
require bacterial growth. This is important because other published studies have
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demonstrated that bacterial diversity is severely underestimated when based on
culture techniques. It has been estimated that less than 1% of the organisms in
nature are cultivable (32). The application of molecular techniques in medical
diagnostics of infection diseases should provide increased sensitivity in pathogen
identification (6, 14, 43, 48).

Molecular techniques for detection and identification of bacteria
Several molecular techniques have been used for identification of bacterial
pathogens. The polymerase chain reaction (PCR) amplification, followed by
sequence analysis of the product is one molecular technique that can definitively
identify a known organism. PCR amplification allows for selective nucleic acid
sequences to be copied and amplified through repeating cycles of denaturing,
primer annealing, and elongation of DNA (40). In a study by El-Eragi, et al. (14) this
particular molecular method was used to identify Mycobacterium tuberculosis in
patients suspected of having pulmonary tuberculosis. This study consisted of 135
DNA isolates that were cultured from patients. The isolated DNA was PCR amplified
by primers designed for the specific amplification of the rpoB gene. PCR
amplification of the DNA samples confirmed the identification of M. tuberculosis and
provided evidence that their PCR amplification and sequence analysis was 100%
accurate in identification of the pathogen (14). However, this method of identification
required that the bacteria were cultured before the samples were used as template
in the PCR.
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Antibody recognition is another molecular technique that has been shown to
aid in pathogen identification. In one study by Wang, et al. (43) anti-Salmonellaantibody-conjugated to oval-shaped gold nanoparticles easily and specifically
identified Salmonella typhimurium in cultured samples where Escherichia coli was
also present. This identification method for S. typhimurium was based on the
observation of the colorimetric change when aggregation of the nanoparticles
occurred due to binding to the bacteria present (43). This study also required that
the bacteria were first cultured and then used for the molecular detection technique.
A third molecular technique is the restriction digest of DNA to determine the
identity of an organism. Zhan, et al. (48) used HpyCH4 III endonuclease to
differentiate Legionella pneumophila from non- L. pneumophila stains. In this study,
42 ATCC strains of L. pneumophila and of non-L. pneumophila were cultured and
DNA isolation was performed. The enzyme restricted the DNA from L. pneumophila
differently than non-L. pneumophila strains giving different size fragments when the
samples were electrophoresed through an agarose gel (48). Identification was
based on the pattern of the restriction fragments.
All three of these molecular techniques required the bacteria to be cultured
and were designed to detect a specific organism. One molecular technique, a
microarray, also detects specific organisms, but can at one time detect several
hundred specific organisms. This characteristic of a microarray is an advantage
when the organism of interest is thought to be among a group of organisms. In one
study, Harrington, et al. (20) designed a microarray with 16S rDNA probes that
would identify 162 gastrointestinal bacteria. Fecal samples were obtained from
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healthy individuals or patients suffering from ulcerative colitis and the genomic DNA
was extracted using the QIAamp DNA Stool Mini Kit (Qiagen). In this study, the
microarray results were sensitive and provided new evidence of the complex
population of gastrointestinal tract bacteria. However, it must be stressed that all of
these molecular techniques require some knowledge about the suspected bacteria
to be identified.
Some molecular techniques allow for unbiased screening of bacteria. These
methods usually include using PCR amplification of the 16S rRNA gene, followed by
sequence analysis for identification. The 16S rRNA gene has been used to examine
bacterial phylogeny and taxonomy, since it was first studied by Carl Woese in 1970s
and the collection of 16S rRNA gene sequences has grown each year (36). The
16S rRNA gene is unique in that it is present in essentially all bacteria. The function
of the gene has not changed over time and it is of sufficient size (1,500 bp) for DNAbased bioinformatics (22). The 16S rRNA gene is composed of alternating regions
of DNA that are conserved among all bacterial species and DNA that is variable or
unique at the species level (Figure 1). This characteristic allows for primers
designed to hybridize to the conserved regions of the gene, to amplify the desired
variable sections of the DNA, so that the latter regions can be used to speciate
among the thousands of known bacteria (3, 9, 45).
The 16S rRNA gene amplification and sequencing method has been used in
various studies to detect and identify bacteria (40). Al Masalma, et al. (1) identified
bacteria in brain abscesses using PCR amplification followed by cloning of the PCR
amplified 16S rDNA and then DNA sequence analysis of the inserted PCR
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Figure 1: E. coli 16S rRNA gene sequence annotated with bacteria and
“universal” priming sites and variable regions V1–V9. The sequence is color
coded to indicate bacterial sequence variability. Dark red = totally conserved. Red =
conserved. Black = variable. Blue = highly variable. Green = > 75% variable. Green
= variable regions. Black = priming sites. From reference # 3.
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fragment. Cloning was used in this study to separate mixed species PCR products
in order to obtain a readable DNA sequence for analysis. The separation of PCR
products is required if more than one species of bacteria is present in a sample.
Cloning allows for a single PCR product to be incorporated into a vector, and then
transformed into one E. coli cell. Colonies arising from the individual E. coli cells
carrying the vector and insert are isolated. In this study in which 125 colonies per
specimen were analyzed, it was determined that the molecular technique identified
more bacterial species than culture analysis. Some of these species included the
anaerobes, Fusobacterium nucleatum, Porphyromonas endodontalis, and
Prevotella oris. M. faucium was another bacterial species identified that had never
been previously associated with brain abscesses. Bittar, et al. (6) used a similar
molecular technique to identify pathogens in cystic fibrosis patients. However, in this
study only 40 colonies per specimen were analyzed. Since cloning randomly
incorporates the PCR products into the vector, the number of colonies needed for
analysis is large to provide a high probability that all the unique PCR product
sequences amplified are identified. This study also identified bacterial species that
had not previously been observed in cystic fibrosis patients.
A more recent molecular technique, termed “pyrosequencing” has been used
to bypass the cloning step in the analysis of the 16S rRNA gene. In this approach
the DNA sequencing procedure examines many single strands of DNA. This is
accomplished using a method termed “sequencing by synthesis” (Figure 2).
“Sequencing by synthesis” occurs using a DNA polymerase that generates
inorganic pyrophosphate each time it adds a nucleotide. The pyrophosphate forms
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Figure 2: Theory of pyrosequencing. Each peak in the pyrograms represents a
pulse of light detected in the instrument. From reference # 15.
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ATP and there is an ATP-dependent conversion of luciferin to oxyluciferin. When
oxyluciferin is formed it causes the emission of light pulses. The amplitude of each
light pulse is directly related to the presence of nucleosides and each type of
nucleotide is released separately. This means that for a single time period only one
type of nucleotide is released and if that nucleotide is incorporated into the DNA
sequence a light pulse will be detected. If the light pulse is doubled then two
nucleotides of the same type were incorporated in the DNA sequence.
Pyrosequencing allows thousands of sequences to be generated from one PCR
reaction. However, one significant limitation of pyrosequencing is that the DNA
sequence retrieved is usually no longer than 400 bases (15). In one clinical study by
Dowd, et al. (13) 193,890 sequences were generated and analyzed from 4 samples.
Using the pyrosequencing technique the authors found greater diversity in chronic
wounds then had previously been identified by culture techniques. Specially, the
pyrosequencing method detected more strict anaerobes in the chronic wound
samples than did the culture method. This new sequencing technique is rapid and
sensitive, but at this time it is still too costly for routine use to identify pathogens. For
general identification of bacterial pathogens, a molecular method that is unlimited in
the number of detectable species and is not prohibitively costly would be useful.
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16S rRNA gene PCR-DGGE molecular method
The first goal of this project was to test a rapid, sensitive, and cost-effective
molecular technique that could identify all possible bacterial pathogens in
musculoskeletal infections. The second goal was to apply this method in a pilot
study of 50 human tissue samples. The molecular method of choice used PCR
amplification of the 16S rRNA gene to identify all possible bacterial species. If all of
the specimens were monomicrobial, then direct sequence analysis of the initial PCR
product could be used for identification of the bacterial pathogens. However, a
complication to this approach was that the majority of musculoskeletal infections are
polymicrobial, which prohibited direct DNA sequencing of the initial 16S rDNA PCR
product. One way to solve this problem was to use denaturing gradient gel
electrophoresis (DGGE) to separate the PCR products into individual bands based
on their melting point. The separation of the PCR products is based on the principle
that each double-stranded DNA (dsDNA) fragment has a unique denaturation point,
which is based on the order of the specific nucleotides of which it is composed.
When DNA is in a denaturing environment, it will begin to denature in specific
regions. The temperature at which the DNA begins to denature is called the melting
point temperature. Chemical reagents, such as urea and formamide, can also be
used to denature dsDNA. The differences in denaturation points of dsDNA can be
detected by electrophoresis through an acrylamide gel containing a gradient of urea
and formamide. To create greater separation between distinct dsDNA, the
concentrations of urea and formamide can be modified. By increasing the gradient
concentrations a larger range of denaturing conditions can be provided. A
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denaturant gradient is formed by using gradient maker. A constant temperature of
60°C also contributes to the denaturation of the dsDNA. Once the dsDNA starts to
denature, its movement through the acrylamide gel will be arrested. The dsDNA
with a lower denaturation point will migrate and stop earlier (or higher) in the
acrylamide gel whereas, the dsDNA with a higher denaturation point will migrate
longer and stop lower in the acrylamide gel. The differences in migration will result
in DNA bands at different positions in the DGGE gel.
The 16S rRNA gene PCR-DGGE molecular method should allow the
identification of all causative bacteria present in the tissue samples. This analytical
technique allows a mixture of PCR products of the same length that electrophorese
through agarose gels as one band, to be separated into different bands that can
then be used as template for DNA sequence analysis. In this case, the DGGE
allows for the detection of individual bacterial species in polymicrobial infected
tissue, which is critical for identification and assessing diversity (10). Combining the
16S rDNA amplification and the DGGE techniques together should provide more
complete information to the medical staff treating these infections than is currently
provided by the clinical microbiology laboratory. The advantages of this alternative
method are that it should increase sample sensitivity and the speed of detection.
Furthermore, bacteria that are non-culturable or in low abundance can be detected
using this molecular method. Infections, particularly those resulting from
polymicrobial biofilms, are difficult to eradicate, making proper identification of the
causative agents critical for treatment.
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METHODS

Origin of bacterial control strains and experimental tissue samples
The standard control strain used for this study was a clinical isolate of
Staphylococcus aureus, from an osteomyelitis infection, designated UAMS-1, which
was purchased from the American Type Culture Collection as ATCC 94250. During
all steps of the analyses, positive and negative controls were included. The tissue
samples were obtained from the Memorial Hermann Hospital Clinical Microbiology
Laboratory after culture analysis was performed. The collection of specimen
occurred throughout the study; some were collected as early as 2007. All the
tissues used in this study were obtained as part of our ongoing trial study, which
has been approved by the IRB - the Committee for the Protection of Human
Subjects at UTHSCH. All patient identification was removed and each tissue sample
was assigned a study number. All tissue samples were stored at -20°C until DNA
isolation from tissue was performed. The amount of time spent in storage varies for
each specimen.

DNA isolation from tissue biopsies
DNA isolation from tissue was performed by using a modified version of the
Puregene DNA Purification kit (Qiagen) for solid tissue. The tissue (0.5 g) was
homogenized in cell lysis solution (500 ul) using a sterile disposable tissue grinder
(Kendall). These steps of the protocol were performed under a tissue culture hood
and all instrumentation and a few solutions (cell lysis solution and sterile water)
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were exposed to UV light for 30 min before the DNA isolation was performed. The
homogenized tissue samples were incubated for 100 min at 65°C. Afterward, 6 ul
Proteinase K solution (20 mg/ml) was added and the sample was incubated at 55°C
overnight. To ensure efficient lysis of the bacterial cells and complete digestion of
cell walls, 10 ul lysotaphin (2 mg/ml) and 3 ul Lytic Enzyme Solution (Qiagen) were
added and the samples were incubated at 37°C for 3 hrs, followed by heating to
80°C for 5 min. This step of the protocol was optimized for S. aureus and it
efficiently lyses other bacteria including Gram-negative organisms, such as E. coli.
Protein precipitation was performed by adding 200 ul of protein precipitation solution
(10 M ammonium acetate), which was followed by the placing samples on ice for 20
min. The samples were then centrifuged at 15,000 x g for 6 min to collect the
supernatant. The supernatant was transferred to a clean microcentrifuge tube.
Again the sample was placed on ice for 20 min and centrifuged to collect the
supernatant. The supernatant containing the DNA was then transferred to a clean
microcentrifuge tube containing 700 µl 100% isopropanol. The microcentrifuge tube
was then mixed and centrifuged at 15,000 x g for 6 min. The supernatant was
discarded and 800 µl 70% ethanol was added to wash the DNA pellet. The samples
were centrifuged at 15,000 x g for 2 min to position the DNA pellet at bottom of the
tube. The ethanol was discarded and the pellet was allowed to air dry for 1 hr. The
DNA pellet was hydrated overnight at room temperature with water that had been
treated with ethidium monoazide bromide (EMA, 9 ug/ml) (see Results). The DNA
isolation protocol duration was two days.
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Initial PCR amplification
DNA amplification was performed as follows. A positive control of S. aureus
DNA and blank were included in all DNA amplification steps. Three different
concentrations of the tissue-extracted DNA were used as the PCR template
(undiluted, 1:10 dilution, and 1:100 dilution). This is an important step in the PCR
amplification protocol because large quantities of DNA can decrease the efficiency
of the PCR reaction. The PCR amplification cocktail included 10X buffer, 5X Q
buffer, 25 mM MgCl2, 10 mm dDNTP, the forward primer (10 pmol/ µl), the reverse
primer (10 pmol/ µl), and HotStar Plus Taq (5 units /µl). The oligonucleotide primers
used were designed based on the known conserved regions that will amplify
variable regions V3, V4 and V5 of the 16S rRNA gene. The primers used were
380F: 5’CCAGACTCCTACGGGAG GCAG‘3 and 907R: 5’ CCG TCA ATT CMT
TTG AGT TT (3). The thermocycler was programmed for the following steps: an
initial denaturing step of 95°C for 5 min; ten cycles of 94°C, 60°C, 72°C for 30 sec
each; then 35 cycles of 94°C, 54°C, 72°C for 30 sec each. The final step for
elongation of the DNA was 10 min at 72°C. The water used in the PCR contained
EMA (9 ug/ml) to eliminate contamination in the PCR reagents and PCR tubes (see
the Results section below). A 1.5% agarose gel electrophoresis was performed after
every DNA amplification to ensure amplification and no contamination.
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Generation of the PCR product for DGGE
A second DNA amplification was performed to generate a PCR product for
DGGE analysis. This amplification conditions was identical to the initial PCR
reaction, except that the oligonecleotide primers used amplified the variable regions
V3 and V4 only, and the reverse primer contained a high GC region on the 5’ end.
This region was selected because an alignment of the 16S rRNA gene of the most
reported bacterial pathogens in musculoskeletal infections revealed that these
variable regions provide enough sequence information to speciate almost all of the
pathogens (Table 1). The primers used were 380F (see above) and 759R
CGV3V4:5’CGCCGCGCGCGGCGGGCGGGGCGGGGCGGGGGGCCGCATT
YCACCKCTACAC’3. The template for this PCR reaction was the PCR product from
the first PCR amplification, which had been diluted to less than a nanogram of DNA
per microliter (usually a 1:100 dilution).
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Bacterial species associated with musculoskeletal infections
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.

Achromobacter xylosoxidans (9)
Acinetobacter baumannii* (9)
Acinetobacter calcoaceticus (9)
Acinetobacter lwoffii* (16)
Actinomyces israelii* (9)
Actinomyces meyeri (9)
Aerococcus viridans (9)
Alcaligenes faecalis (16)
Alkane-degrading soil bacterium MVAB Hex1 (9)
Anaerococcus vaginalis (16)
Arcanobacterium pyogenes (9)
Bacillus cereus (9)
Bacteriodes fragilis* (9)
Brucella melitensis (9)
Burkholderia cepacia (9)
Burkholderia gladioli (39)
Campylobacter jejuni (9)
Citrobacter diversus (9)
Citrobacter freundii (19)
Clostridium botulinum* (9)
Clostridium septicum (9)
Comamonas terrigena (16)
Corynebacterium confusum(18)
Corynebacterium jeikeium* (9)
Corynebacterium striatum (16)
Coxiella burnetii (9)
Eikenella corrodens (19)
Enterobacter aerogenes* (9)
Enterobacter hormaechei*(9)
Enterococcus gallinarum (9)
Enterococcus faecium* (9)
Escherichia coli*(9)
Escherichia vulneris (9)
Faecalibacterium prausnitzii (9)
Francisella tularensis (9)
Fusobacterium alocis (9)
Fusobacterium equorum (9)
Fusobacterium naviforme (9)
Fusobacterium necrophorum (9)
Fusobacterium nucleatum (9)
Fusobacterium periodonticum (9)
Fusobacterium sulci (9)
Granulicatella adiacens (16)
Haemophilus aphrophilus (9)
16

45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.

Haemophilus parahaemolyticus (9)
Haemophilus parainfluenzae (9)
Haemophilus paraphrophilus (9)
Haemophilus pittmaniae (9)
Kingella kingae (16)
Klebsiella pneumonia* (9)
Leclercia adecarboxylata (16)
Leptospira interrogans (9)
Listeria grayi (9)
Listeria monocytogenes (9)
Moraxella catarrhalis (9)
Morganella morganii* (16)
Mycobacterium avium (9)
Mycobacterium fortuitum (9)
Mycobacterium goodii (8)
Mycobacterium gordonae (9)
Mycobacterium haemophilum (38
Mycobacterium intracellulare (9)
Mycobacterium kansasii (9)
Mycobacterium malmoense (44)
Mycobacterium marinum (42)
Mycobacterium tuberculosis (9)
Mycobacterium wolinsky (8)
Mycobacterium xenopi (12)
Mycoplasma pneumoniae (24)
Neisseria lactamica (9)
Neisseria meningitis (28)
Nocardia brasiliensis (9)
Oligella urethralis (9)
Pasteurella multocida* (37)
Peptoniphilus lacrimalis* (16)
Peptostreptococcus hareii* (16)
Peptostreptococcus micros* (9)
Porphyromonas asaccharolytica (16)
Porphyromonas somerae* (16)
Prevotella bivia* (16)
Prevotella buccalis* (16)
Prevotella disiens (19)
Proteus mirabilis* (9)
Proteus vulgaris (9)
Providencia stuartii (19)
Pseudomonas aeruginosa* (9)
Pseudomonas putida (19)
Pseudomonas stutzeri* (33)
Ralstonia pickettii (35)
Rhodococcus equi (9)
17

91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.

Rickettsia rickettsii (9)
Rochalimaea henselae (9)
Salmonella paratyphi A (9)
Salmonella typhimurium (9)
Serratia marcescens* (9)
Shewanella algae (7)
Shigella dysenteriae (9)
Sphingobacterium mizutae (9)
Staphylococcus aureus* (9)
Staphylococcus capitis (16)
Staphylococcus caprae (9)
Staphylococcus epidermidis* (9)
Staphylococcus haemolyticus (9)
Staphylococcus hominis (9)
Staphylococcus intermedius (9)
Staphylococcus lugdunensis (9)
Staphylococcus saprophyticus (9)
Staphylococcus schleiferi (9)
Staphylococcus simulans* (9)
Staphylococcus warneri (9)
Stenotrophomonas maltophilia (16)
Streptococcus agalactiae* (28)
Streptococcus gordonii (9)
Streptococcus sp. 'group G' * (19)
Streptococcus iniae (25)
Streptococcus pyogenes (9)
Streptococcus salivarius (9)
Streptococcus uberis (9)
Streptococcus viridans (19)
Veillonella parvula (16)
Vibrio cholerae (9)
Yersinia enterocolitica (9)

Table 1: Bacterial species in the 16S rRNA gene alignment previously
identified as the causative agents in musculoskeletal infections. Names of
bacteria species reported to be the causative agents of musculoskeletal infections,
which was used for the alignment of the 16S rRNA gene that revealed that variable
regions 3 and 4 provide enough sequence information to speciate most of the
pathogens. Bacterial species with an asterisk (*) indicate that it was identified by the
16S PCR molecular method. References are listed in the parentheses.
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Denaturant gradient gel electrophoresis
After obtaining the second PCR product, this PCR product was separated
using DGGE, which used the Bio-Rad DCode system for the casting of the gel and
electrophoreses (4). The denaturing gradient gel used was composed of 6-10%
acrylamide/bis and a 30-70% denaturing solution of urea and formamide. The 30%
denaturing solution contains 12 ml of formamide and 12.6 g of urea. The 70%
denaturing solution contains 28 ml of formamide and 29.4 g of urea. The proper gel
concentration was determined by comparing band migration and separation in a
variety of gel concentrations: 6%, 8%, 6-10%, and 8-10%, acrylamide/bis and 3070% and 40-70% denaturant solution. The addition of 10% ammonium persulfate
and TEMED served to catalyze the gel polymerization. The gradient gel was
allowed to polymerize for 2 hrs at room temperature and was stored at 4°C
overnight. The running buffer (0.5 TAE) was heated to 60°C before the samples
were loaded into the wells. Each sample contained PCR products varying in DNA
concentration (200 ng to 1ug) and 2x loading dye. The minimum DNA
concentration, 200 ng, that can be detected with a UV light source and GelRed
Nucleic Acid stain (Biotium) at 3X concentration (5) was determined by loading
decreasing amounts DNA of the control stain of S. aureus. The duration of
electrophoresis was 15 hrs at 100 V. This condition was determine by comparing
band migration and separation in gels that had run for various times and voltages.
Once electrophoresis was completed the gel was removed from the DGGE
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chamber and stained with GelRed stain (3X) for 45 min. The gel was viewed under
UV light and all bands were excised using sterile scalpel blades.

DNA extraction of DNA from DGGE bands
Several methods for DNA extraction from the DGGE bands were explored.
One method was extraction of DNA using the QIAquick gel extraction kit (Qiagen)
modified for acrylamide gels based on the manufacturer’s recommendations.
Second, a small piece of gel slice was placed directly into the PCR tube to serve as
the DNA template in a PCR reaction. Third, the gel slice was cut into pieces and
placed in a centrifuge tube with water and left overnight. The DNA would then
diffuse into the water, which served as the template for PCR. The fourth method
involved shredding the gel slice by bead beating it in a 1.7 ml microcentrifuge tube
containing 0.2 g of glass beads in 0.5 ml of water overnight at a setting of 4°C. This
solution then served as the DNA template for PCR. The fourth method was the most
successful template to produce PCR products, as a result it was the method of
choice and included in the optimized protocol.

PCR of DNA extracted from DGGE bands
DNA amplification of the DGGE gel extracted DNA was performed using Fail
Safe polymerase (Epicentre Biotechnologies). This polymerase was tested and was
more efficient then the Hot Star Plus Taq (Qiagen), used in the initial PCR.
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In the development of this method a few other were tested. First, a shorter
reverse primer without the GC region was used, however, with this primer the PCR
was less efficient. In addition, the GC reverse primer containing the long GC region
was tested and showed better amplification of the DNA, but it produced an
extensive amount of primer dimers. These primer dimers were a problem in the
subsequent sequencing reaction. An agarose gel extraction using the Mini Qiagen
kit was used to purify the PCR product in this case.
The primers used were forward and reverse primers that contained linker
regions with either AT or GC in content (31). 380F-AT-M13: 5’- GTAAAACGA
CGGCCAGTAATTAAAATAAAAATGAAAAAAACCAGACTCCTACGGGAGGC -3’.
759R-CG-M13: 5’- CAGGAAACAGCTATGACGGGCGGGGCGGGGGCACGG
GGGGCGCATTYCACCKCTACAC -3’. These primers were chosen to create a
buffer region for the sequencing reaction. This resulted in a DNA sequence that
begins 40 base pairs upstream of the actual bacterial DNA sequence. This ensured
that the entire 16S rDNA sequence was available for analysis. Also, these primers
do not form primer dimers and as a result an agarose gel extraction step is not
required. These primers were shown to be the most efficient in production of PCR
products and allowed complete bacterial DNA sequencing.

DNA sequencing and analysis of the PCR products extracted from the DGGE
gel slices

To perform DNA sequencing, the purified PCR products were first incubated
with the Exo SAP-IT enzyme to digest the single-stranded DNA in the reaction,
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unconsumed dNTPS and primers. ExoSAP-IT contains two hydrolytic enzymes,
Exonuclease I and Shrimp Alkaline Phosphatase. The Exonuclease I enzyme
removes the unused primers in the PCR reaction. The Shrimp Alkaline
Phosphatase removes the residual dNTPs from the PCR reaction (41). The DNA
sequencing reaction was performed as followed: 20 ng of the PCR product was
added to Big Dye, 5X sequencing buffer, and forward primer (10 pmol/ µl). The Big
Dye and 5X were reagents supplied by the Center for Clinical and Translational
Sciences Genetics Core Lab of the University of Texas Medical School at Houston.
The DNA sequencing reaction was performed on a thermocycler with the following
program for 35 cycles: 96°C for 15 sec, 55°C for 15 sec, 65°C for 2 min. The
sequencing reaction products were purified using Sam solution and Big Dye
Xterminator, which were supplied by the Genetics Core Lab. The sequencing
products were analyzed using the ABI 3137 XL in the Genetics Core Lab. DNA
sequencing was performed on the control strains and the DGGE PCR products.
Even though the DGGE PCR products appeared to not have primer dimers in the
agarose gel, the sequence obtained from some of these PCR products was not
always reliable. Several modifications of the sequencing reaction were tested,
including increasing the amount of nucleotide dyes used per sequencing reaction,
decreasing the DNA concentration used in sequencing reaction to 20 ng, and
altering the temperatures of the thermocycler steps. None of the modifications
tested significantly improved the DNA sequence quality. However, the addition of
linker primers (see above) (31) to the 3’ end and the 5’ end of the PCR product
used for sequence analysis did improve the percentage of identify to the known
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sequences. The linker primers allowed for the full PCR product sequence to be
analyzed. DNA sequences that did not have significant background signal were
analyzed by searching the bacterial database (30) with the complete sequence
using the National Center for Biotechnology Information’s Basic Local Alignment
Search Tool (BLAST) nucleotide-nucleotide server (2). Identification was based on
the comparison that provided the highest degree of identity. All identifications
including speciation were defined as having a > 90% identity to a known 16S rDNA
sequence in the nucleotide database when compared with the BLAST sequence
results.
Overall the 16S rRNA gene PCR-DGGE method includes several critical
steps: DNA extraction from tissue biopsies, amplification of the bacterial DNA, PCR
product separation by DGGE, amplification of the gel-extracted DNA, and DNA
sequencing and analysis (Figure 3). This method can detect the presence of
bacteria in 3 days by PCR amplification of the 16S rRNA gene and can identify the
organisms in 5 days by DNA sequence analysis.
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Figure 3: Overview of 16S rRNA gene PCR-DGGE method. This method
includes DNA extraction from tissue biopsies, amplification of the bacterial DNA,
PCR product separation by DGGE, amplification of the gel-extracted DNA, and DNA
sequencing and analysis.
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RESULTS
Section 1: Optimization and validation of the method
Isolation of DNA
Limit of detection for DNA extraction
Efficient lysis of the bacterial cells is important to achieving high efficiency
and sensitivity for the 16S rRNA gene PCR-DGGE molecular detection technique.
The isolation of DNA protocol used in this study was modeled after the Puregene
DNA Purification kit (Qiagen). Several modifications were made to the Puregene kit
(Qiagen) that increased the efficiency of bacterial cell lysis. S. aureus was used as
a model bacterial cell because it is a common pathogen in musculoskeletal
infections and requires specific steps for efficient cell lysis. The high degree of
crossing-linking of the pentaglycine bridge between the ε-amino group of lysine and
the terminal D-alanine of an adjacent tetrapeptide makes the S. aureus cell wall
extremely strong and difficult to lyse (23). For efficient cell lysis of S. aureus the
addition of lysostaphin (2 mg/ml) to the DNA isolation protocol was important. To
test how efficient the DNA isolation protocol was, an experiment using a range of S.
aureus cells (2 to 2,000) was used in the DNA isolation protocol. The PCR products
of the resulting extracted DNA were electrophoresed through a 1.5% agarose gel
and visualized after staining with ethidium bromide. The PCR product resulting from
the extracted DNA showed that this DNA isolation protocol was able to detect at
least 20 bacterial cells (Figure 4). These data indicate that this method is very
sensitive. It is interesting to note that when less DNA that was used as the template,
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Figure 4: The limit of detection for DNA extraction. The PCR products of
extracted DNA from different numbers of S. aureus cells ranging from 2 to 2,000
was electrophoresed through a 1.5% agarose gel and visualized after staining with
ethidium bromide. The PCR product of the extracted DNA shows that the DNA
isolation protocol method is able to detect at least 20 bacterial cells.
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there was more PCR product synthesized. These results indicate that the PCR
reaction is a more effective reaction with a limited amount of DNA template.

PCR amplification
The optimization of EMA concentration
Ethidium monoazide bromide (EMA) is a photoreactive chemical that is an analogue
of ethidium bromide. EMA contains an azide group in the eighth position, whereas
ethidium bromide contains an amino group in that position (Figure 5). When EMA is
exposed to a long wavelength (> 400 nm), the azide group covalently crosslinks
with nucleic acids. Any nucleic acid that becomes crosslinked with EMA will be
unable to serve as template for PCR amplification reaction (34). The ability of EMA
to bind to nucleic acids can be used to eliminate contaminates from being amplified
along with the template. This is important because amplification of contaminates
can give misleading results. In this study EMA was only used for the pretreatment of
the PCR reaction mix prior to the addition of the template DNA. To determine the
appropriate range of EMA necessary for the elimination of contamination in PCR
reactions, 0.1 pg of S. aureus DNA was added to each PCR reaction to serve as
artificial contamination in one of the PCR amplification reagents. Also added were
various amounts of EMA: 5 ug/ml, 10 ug/ml, 15 ug/ml, 20 ug/ml; and there was a
tube with no added EMA. After the addition of the EMA the PCR reaction was
exposed to a halogen light for 5 minutes. All the PCR reactions were amplified as
described previously. The PCR products were electrophoresed through 1.5%
agarose gel and visualized after staining with ethidium bromide. The PCR reaction
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Figure 5: Structural comparison of ethidium monoazide bromide to ethidium
bromide. Ethidium monoazide bromide (EMA) (Panel A) is a photoreactive
chemical that is an analogue of ethidium bromide (Panel B). EMA contains an azide
group in the eighth position where as ethidium bromide contains an amino group.
When EMA is exposed to a long wavelength (> 400 nm) the azide group covalently
cross links with nucleic acids and prevents their amplification in a PCR reaction.
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that contained no EMA and no standard template (blank) showed amplification of
the artificial contaminant DNA. However, when EMA at 5 ug/ml or more was added
to the PCR reaction before the addition of the standard template DNA, no
amplification of the artificial contaminant DNA was observed. This is important to
ensure that reagent contamination was not amplified during the PCR reaction. The
PCR reactions in which EMA was added at concentrations of 10, 15, and 20 ug/ml
seemed to be less efficient in amplification of the template DNA (Figure 6). We
chose to use 10 ug/ml of EMA to decontaminate the reagents in the standard
protocol. However, 5 ug/ml of EMA would have been a better choice.

The limit of detection for PCR amplification
The PCR amplification of the chromosomal DNA is an important step for the
16S rRNA gene PCR-DGGE method. It is essential that this step be efficient and
sensitive in amplifying the variable regions V3, V4, and V5 of the 16S rRNA gene.
To determine the efficiency and sensitivity of the PCR amplification, various
amounts of S. aureus DNA were used as template for the PCR reaction (0.01 pg to
1 pg). This range of S. aureus DNA is approximated to be equal to the DNA in 3 325 cells base on a chromosome of 3 Mb per cell (30). The PCR amplification was
performed using the protocol described previously. The PCR products were
electrophoresed through a 1.5% agarose gel and visualized after staining with
ethidium bromide. The agarose gel showed that the limit of detection was between
0.01 pg – 0.05 pg of S. aureus DNA, which is equivalent to 3-15 cells.
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Figure 6: The range of EMA necessary to eliminate PCR contamination for
PCR. S. aureus DNA (0.1 pg) was added to each PCR reaction to serve as an
artificial contamination of the PCR amplification reaction. Also added were various
amounts of EMA, 5 µg/ml, 10 µg/ml, 15 µg/ml, 20 µg/ml or no EMA. After the
addition of the EMA the PCR reaction was exposed to a halogen light for 5 min. All
the PCR reactions were subjected to PCR amplification cycle described previously.
The PCR products were electrophoresed through a 1.5% agarose gel and
visualized after with ethidium bromide. The PCR reaction that contained no EMA
and no standard template showed amplification of the artificial contaminates.
However, when 5 ug/ml of EMA or above was added to the PCR reaction before the
addition of the template DNA, no amplification of the artificial DNA contamination
was observed.

30

A PowerWave microplate spectrophotometer (BioTek) was used with a Gen5 data
analysis software to determine the S. aureus DNA concentration used (Figure 7).
A second PCR reaction was performed to determine if the PCR amplification
would be altered in its efficiency in the presence of human DNA. Two different
concentrations of human DNA were added to the PCR reactions: 19 ng and 190 ng.
These concentrations reflect the concentration of the human DNA that was typically
present in 1:10 and 1:100 dilutions of tissue samples, respectively. Each
concentration of human DNA was added to PCR reactions with various amounts S.
aureus DNA as template, 0.01 pg, 0.5 pg, 1 pg, and 125 pg. As described above,
DNA concentrations were determined with a microplate spectrophotometer. The
PCR amplification was performed according to the PCR amplification protocol
described previously. The electrophoresis of the PCR products on a 1.5% agarose
gel indicated that in the presence of human DNA less than 100 ng the efficiency of
PCR amplification is greater and the sensitivity is increased from 0.05 pg to 0.01 pg
of S. aureus DNA (Figure 8). This is somewhat surprising and interesting in the light
that all of the samples that were analyzed contained human tissue. The results
from both PCR amplification experiments showed that the presence of human DNA
in the PCR reaction seemed to increase the sensitivity of the reaction. In the
presence of human DNA the limit of detection was decreased to 0.01 pg of S.
aureus DNA.
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Figure 7: The limit of detection for PCR using S. aureus DNA as template. DNA
from S. aureus cells ranging from 0.01 pg to 1 pg was used as template in the PCR
amplification reaction using PCR conditions describe previously. The limit of
detection for PCR amplification using S. aureus DNA is at least 0.05 pg.
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Template concentration

Human DNA concentration

Figure 8: The limit of detection for PCR using S. aureus DNA as template in
the presence of human DNA. Two different concentration of human DNA was
added to the PCR reaction, 2 ng and 19 ng. Each concentration of human DNA was
added to PCR reactions with various amounts S. aureus DNA as template, 0.01 pg,
0.05 pg, 1 pg, and 125 pg. The PCR amplification was performed according to the
protocol describe previously. The PCR products were electrophoresed through a
1.5% agarose gel and visualized after with ethidium bromide. The results from the
agarose gel show that the limit of detection for PCR using S. aureus DNA in the
presence of human DNA is at least 0.01 pg.
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DGGE gel electrophoresis
Determining the most appropriate preparation of the DGGE gel
Two methods to distribute the unpolymerized acrylamide into the DGGE
system were tested: a 475 gradient former that is included in the Bio-Rad DCode
system and a gravity gradient maker. The 475 gradient former uses two syringes to
hold the different liquid acrylamide concentrations, which are moved by a calibrated
wheel to form the gel (Figure 9). The second method uses a gravity gradient maker
that is connected to a peristaltic pump. To test the two gradient forming devices the
high concentration denaturing solution was stained with red food dye. Once the gels
solidified they were scanned and pixel analysis determined that the gravity gradient
maker made the gradient gel with the most gradual and consistent gradient.
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Figure 9: Bio-Rad DCode DGGE apparatus. The DGGE gradient maker uses a
calibrated wheel apparatus to dispense the high and low denaturing solution to cast
a gradient gel. The wheel applies selective pressure to two syringes containing the
high and low concentrations of the denaturing solution. The two solutions flow
through the plastic tubing where they become mixed and poured in between two
glass plates.

35

Determining the appropriate amount of acrylamide and denaturing gradient
It is necessary for the DGGE gradient be large enough to separate closely
related PCR products. To test which concentration gradient would be the most
appropriate, several concentrations of acrylamide and denaturing gradient were
tested. These concentrations included: 8%, 8-10%, and a 6-10% acrylamide. These
gels were loaded with 500 ng of PCR products amplified from the 16S rDNA of
Staphylococcus aureus, Enterobacter hormaechei, and Acinetobacter baumannii. A.
baumannii and E. hormaechei were chosen because the two bacterial DNA PCR
products migrate and stop at the top and bottom of the DGGE gel, respectively. The
denaturing solutions tested were 40-70% and 30-70%. From these trials, the gel
concentration of 6-10% acrylamide and 40-70% denaturing solution was determined
to have the best separation for the bacterial DNA tested (Figure 10).

Determination of the most appropriate duration of denaturing gradient gel
electrophoresis
It was important to determine the amount of time necessary for the PCR
products to migrate to their melting point positions, otherwise PCR product
separation may not occur. To determine the correct running time for the DGGE gel,
340 ng of S. aureus DNA was loaded into the denaturing gradient gel wells every
two hrs for 10 hrs. The DNA bands at 8 and 10 hr migrated the same distance in
the denaturing gradient gel. This shows that the DGGE needs at least 8 hrs for
maximal migration (Figure 11).
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Figure 10: Determining the most appropriate amount of acrylamide and
denaturing gradient. Panel A: This DGGE gel is comprised of 8% acrylamide/Bis
with 40-70% denaturing solution. Panel B: This DGGE gel is comprised of DGGE 810% acrylamide/Bis with 30-70% denaturing solution. Panel C : This DGGE gel is
comprised of 6-10% acrylamide/Bis with 40-70% denaturing solution. Panel D: This
DGGE gel is comprised of 6-10% acrylamide/Bis with 30-70% denaturing solution.
Several concentrations of acrylamide and denaturing gradient were tested. The 8%
acrylamide/bis and 8-10% acrylamide/bis were run with 500 ng of S. aureus, E.
hormaechei, and A. baumannii. The denaturing solutions tested were 40-70% and
30-70%. From these trials, the gel concentration of 6-10% acrylamide and 40-70%
maximal migration denaturing solution was determined to have the best separation
for the bacterial DNA tested.
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Figure 11: Determining the most appropriate duration of denaturing gradient
gel electrophoresis. Electrophoresis of S. aureus DNA (340 ng), which was
applied to the gel every two hours for ten hours. The DGGE gel was composed of 610% acrylamide/bis with 30-70% denaturing solution and electrophoresed at 100 V.
The DNA bands (lanes 1 and 2) at 8 and 10 hrs migrated the same distance in the
DGGE gel. Lane 1 = 10 hrs, lane 2 = 8 hrs, lane 3 = 6hrs, lane 4 = 4 hrs, lane 5 = 3
hrs.
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Determination of the most appropriate amount of DNA to load into the DGGE
Visualization of the DNA bands in the DGGE gel is important for the recovery
and re-amplification of the DNA for sequencing analysis. To determine the amount
of DNA needed for visualization with Gel Red stain under UV light, a range of 50 ng
-500 ng of S. aureus and A. baumannii DNA was loaded into the DGGE gel and
electrophoresed using our standard conditions, for 15 hrs at 100 V. The 50 ng
loading of S. aureus and A. baumannii were still visible under UV light (Figure 12).

Mixed template PCR amplification and DGGE analysis of bacterial strains
DNA isolation from polymicrobial tissue samples would have multiple DNA
templates for PCR amplification. To test the efficiency of PCR amplification of
multiple templates in one reaction, DNA of three bacteria strains, S. aureus,
Enterococcus faecalis, and Enterobacter aerogenes, were PCR amplified together
and separately. 50 ng of each bacterial stain, S. aureus, E. faecalis, and E.
aerogenes served as template separately for PCR amplification. Mixed template
PCR was also performed using all three bacterial DNA as template. One PCR
reaction contained an equal low concentration of DNA from each organism as
template (0.5 ng). A second PCR reaction contained S. aureus (5 ng), E. faecalis
(0.5 ng), and E. aerogenes (50 ng). A third PCR reaction contained an equal high
concentration of DNA from each organism (50 ng). All PCR amplification products
were electrophoresed through a DGGE gel overnight at 100V. The results from this
experiment indicate that the efficiency of mixed template PCR amplification
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1234 56

Figure 12: Determining the
appropriate amount of DNA to
load onto the DGGE.
A: Electrophoresis of various
amounts of S. aureus DNA ranging
from 500 ng to 50 ng.

123456
B: Electrophoresis of various
amounts of A. baumannii DNA
ranging from 500 ng to 50 ng.
1 = 500 ng, 2 = 250 ng, 3 = 200 ng,
4 =150 ng, 5 =100 ng, 6 = 50 ng
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decreased when multiple templates were present. However, higher magnification
analysis of the bands indicates that DNA for all three bacteria can be observed
when equal concentrations of the templates were present (Figure 13 and 14).
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Figure 13: DGGE gel electrophoresis of mixed template PCR products.
Different DNA concentrations of three bacteria strains were PCR amplified together
and separately. The PCR products of each PCR amplification reaction was then
electrophoresed through a DGGE gel overnight at 100 V. Lane 1 = Staphylococcus
aureus (0.5 ng), Enterococcus faecalis (0.5 ng), and Enterobacter aerogenes (0.5
ng). Lane 2 = S. aureus (5 ng), E. faecalis (0.5 ng), and E. aerogenes (50 ng). Lane
3 = S. aureus (50 ng), E. faecalis (50 ng), and E. aerogenes (50 ng). Lane 4 = S.
aureus (50 ng). Lane 5 = E. faecalis (50 ng). Lane 6 = E. aerogenes (50 ng).
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Figure 14: Higher magnification of the DGGE gel electrophoresis of mixed
template PCR products. A higher magnification view of lanes 1-4. Lane 1 = S.
aureus (50 pg), Enterococcus faecailis, and Enterobacter aerogenes (50 pg). Lane
2 = S. aureus (5 ng), E. faecalis (50 pg), and E. aerogenes (50 ng). Lane 3 = S.
aureus (50 ng), E. faecalis (50 ng), and E. aerogenes (50 ng). Lane 4 = S. aureus
(50 ng). Looking closely the DGGE gel reveals bands in lanes 1-3 that are in a
similar position to the S. aureus, pictured in lane 4.
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Section 2: Results of the pilot study of fifty tissue samples

Molecular analysis of 50 tissue samples
The optimized 16S rRNA gene PCR-DGGE method was used to analyze 50
tissue biopsy samples chosen randomly from our collection. Each tissue sample
was subjected to the following steps of the protocol: DNA isolation, PCR
amplification with 16S rDNA and DGGE primers, DGGE electrophoresis, extraction
of DNA gel slices, DNA sequencing and analysis. The DNA sequencing results
were compared to the sequences in the NCBI non-redundant nucleotide database
(30) with the BLAST program (2). Identification for each sample was based on
comparison with the organism whose 16S rDNA sequence had the highest degree
of identity. All identifications were made with > 90% identity with reference
sequence giving by BLAST tool. Each result was compared to the culture results of
the Memorial Hermann Hospital Clinical Microbiology Laboratory listed in the
Memorial Hermann Hospital Electronic Record Resource.
In this study, 17 of the 50 (34%) tissue samples were culture negative. The
molecular method was congruent for ten of the 17 (59%) culture negative tissue
samples. Six of the 10 (60%) congruent tissue samples were obtained from patients
who were not clinically diagnosed with an infection. With this high percentage of
clinically uninfected tissue samples, it is not surprising that the molecular method
was congruent with ten negative culture samples. In seven of the 17 (41%) culture
negative samples the molecular method identified an organism (Table 2).
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Tissue Culture Results
Number

16S PCR-DGGE

23

Negative

Negative

110

Negative

Negative

96

Negative

Negative

1506

Negative

Negative

125A

Negative

Negative

0647

Negative

Negative

111*

Negative

Negative

111B*

Negative

Negative

111E*

Negative

Negative

2217*

Negative

Negative

2764

Negative

Streptococcus agalactiea (99%)

1921*

Negative

Staphylococcus aureus (98%)

2057

Negative

Abiotrophia defectiva (98%)

111C

Negative

Staphylococcus aureus (90%)

3460*

Negative

Gemmatimonadetes (93%)

93*

Negative

Pseudomonas stutzer (93%)

3514

Negative

Acinetobacter sp. (90%)

Table 2: Culture negative tissue samples. Seventeen tissue samples of 50 were
identified as negative by culture. 16S rRNA gene PCR-DGGE method identified 11
out of 50 as negative. Red = congruency. Tissue numbers with an asterisk (*)
indicate that Geobacillus sp. were identified in the sample by the molecular method.
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The culture positive table can be divided into two sections, the monomicrobial and the polymicrobial tissue samples. Eighteen of the 50 (36%) tissue
samples were identified to be mono-microbial by culture techniques. The molecular
method was congruent with the culture identification for seven of the 33 (21%)
positive culture tissue samples. For three of the 18 (17%) samples identified as
mono-microbial by the culture results, the molecular method identified more
organisms. Fifteen of the 50 (30%) tissue samples were identified as polymicrobial
by culture techniques. In 13 of these 15 (87%) the molecular method identified at
least one organism that was also identified by culture techniques. In five of these 15
(33%) samples the molecular method identified addition organisms (Table 3).
In tissue samples 67 and 864 Enterobacter sp. was identified by the
molecular method. However, Enterobacter has an identical DNA sequence to
Klebsiella in the variable 3 and 4 regions which were used for the identification. This
means that for these two tissue samples the identification of an Enterobacter could
also mean an identification of Klebsiella. In order to differentiate between
Enterobacter and Klebsiella specific primers to each bacterium could be used for
PCR amplification. This is the only problem for identification that has arisen.
Throughout tables 2 and 3, some tissue samples have asterisks, this
indicates that Geobacillus sp. was identified in that sample by the molecular
method. Specifically, Geobacillus stearothermophilus spores are widely used for the
validation of moist heat sterilization in autoclaves. Autoclaves are commonly used in
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Tissue
Number
103
0689
2543
3368
2945
2362
3059*
3361

Culture Results

16S PCR-DGGE

Clostridium sp.
Staphylococcus aureus
MRSA
MRSA
Staphylococcus aureus
MRSA
MRSA
MRSA

67*

MRSA

Clostridium sp. (99%)
Staphylococcus aureus (99%)
Staphylococcus aureus (99%)
Staphylococcus aureus (99%)
Staphylococcus aureus (100%)
Staphylococcus aureus (94%)
Staphylococcus aureus (92%)
Staphylococcus aureus (99%),
Corynebacterium sp, (95%)
Streptococcus agalactiae (99%)
Staphylococcus aureus (98%),
Enterobacter sp. (96%)

2920

Staphylococcus sp.

65
127B
117B*
131C*
107
127A
131D*
1216*

Staphylococcus sp.
Pseudomonas aeruginosa
Staphylococcus aureus
Staphylococcus sp.
MRSA
Pseudomonas aeruginosa
Staphylococcus sp.
MRSA

112

MRSA, Serratia marscesens,
Enterococcus sp.
Proteus mirabilis,
Corynebacterium,
Staphylococcus sp.
Streptococcus sp.,
Staphylococcus aureus,
Staphylococcus sp.,
Corynebacterium

97

797*

Staphylococcus simulans (96%),
Corynebacterium sp. (97%)
Corynebacterium sp. (96%)
Clostridium sp. (100%)
Negative
Negative
Negative
Negative
Negative
Negative
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Staphylococcus aureus (95%),
Serratia sp. (99%)
Proteus mirabilis (94%),
Clostridium sp. (98%),
Porphyromonas somerae (94%)
Streptococcus pneumonia
(98%), Candidatus peptoniphilus
massiliensis (96%)

Tissue Culture Results
Number
Group B Streptococcus, Gamma
864
Streptococcus Corynebacterium,
Staphylococcus sp., Prevotella sp.
101

108 *

Beta Hemolytic Streptococcus ,
Pseudomonas aeruginosa , Acinetobacter
baumanii, MRSA
Corynebacterium, Staphylococcus aureus,
Group B Streptococcus

16S PCR-DGGE Results
Streptococcus agalactiae (97%),
Enterococcus faecalis (97%),
Enterobacter (93%)
Streptococcus dysagalactiae (99%),
Corynebacterium (97%)
Corynebacterium sp. (99%),
Actinobacterium sp. (92%)

113*

Pseudomonas aeruginosa, Enterobacter
cloacae, Staphylococcus sp.

1044

Pseudomonas aeruginosa, Enterococcus, Pseudomonas aeruginosa (100%)
Citrobacter freundii

2669

Streptococcus sp., Pseudomonas
aeruginosa, Staphylococcus sp.

Streptococcus anginosus (99%)

1025

Enterococcus sp., Enterobacter
aerogenes, E. coli, Prevotella,
Pseudomonas aeruginosa, Gamma
Hemolytic
Enterococcus sp., Prevotella sp.

Enterococcus faecalis (99%)

Corynebacterium sp., Pseudomonas
aeruginosa,
Gram neg. rods, lactose fermenters,
Achromobacter
MRSA, Staphylococcus sp.,
Corynebacterium
MRSA, Staphylococcus sp.
Corynebacterium sp.

Corynebacterium sp. (90%)

2085
2986
94B*
104*
104B*

Pseudomonas aeruginosa (96%)

Enterococcus faecalis (99%)

Pseudomonas aeruginosa (96%)
Negative
Negative

Table 3: Culture positive tissue samples. Eighteen out of the 50 tissue samples
were monomicrobial. Fifteen out of the 50 tissue samples were polymicrobial. Red =
congruency. Anaerobes are underlined. Tissue numbers with an asterisk (*) indicate
that Geobacillus sp. were identified in the sample by the molecular method.
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medical settings for sterilization of medical instrumentations and medical waste
(26). Geobacillus has not been found to cause human infection, however, it was
present in 12 of the 50 tissue samples. It is possible that the molecular method is
detecting DNA from the Geobacillus spores left in the autoclaves after the validation
of sterilization testing that have contaminated the autoclaved medical instruments
used for the biopsies in this study.
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DISCUSSION
The overall goal of this project was to use PCR amplification of a portion of
the 16S rRNA gene to test an alternative approach for the identification of the
causative agents in musculoskeletal infections and to assess the diversity of the
bacteria involved. The advantages of this alternative method are that it should
increase sample sensitivity and the speed of detection. In addition, bacteria that are
non-culturable or in low abundance can be detected using a molecular method. The
16S rDNA PCR-DGGE method, applied many molecular techniques, which included
several critical steps: DNA extraction from biopsied tissue, amplification of the
bacterial DNA by PCR, PCR product separation by DGGE, extraction and reamplification of the DNA from the gel slices, and DNA sequencing and analysis.
The first goal of this project was to optimize each step of the protocol so that
it was sensitive and rapid as possible. The first step in the protocol to be optimized
was the DNA isolation. The DNA isolation protocol required two days to complete.
Several steps were modified to increase sensitivity. These steps included the
addition of lysostaphin for the efficient lysis of S. aureus cells. Without the addition
of lysostaphin the detection of S. aureus cells was greatly diminished. This is
important because S. aureus is one of the most common pathogens in
musculoskeletal infections. Our results confirmed this to be the case in our 50
samples, as S. aureus was identified in ten samples by the molecular approach and
in 11 by culture.
Another factor that was important in the DNA isolation step was the
prevention of contamination. Contamination was a problem in the beginning of this
study. The use of disposable tissue grinders and UV light treatment of cell lysis
50

solution, sterile water and instruments before DNA isolation was crucial to prevent
contamination. The use of EMA to eliminate DNA contamination of the reagents
was also important.
The second step of the molecular method was PCR amplification of the 16S
rRNA gene. The choice of primers for the PCR amplification was important. The
goal of the molecular method was to identify all possible bacterial causative agents
in musculoskeletal infections. To accomplish this goal, the primers must be able to
hybridize to the conserved regions of the 16S rRNA gene. It was also important that
the variable regions amplified contained enough unique information content to
ensure that an identification of the species could be made. The choice of which
variable region to amplify was based on the comparison of 123 16S rRNA gene
sequences of the most common pathogens in musculoskeletal infections. This
sequence comparison determined that variable region V3 and V4 would be the best
choice for this study because it would speciate almost all of the possible bacterial
organisms.
The third step in this method involves the use of DGGE to separate the 16S
rDNA PCR products present in polymicrobial samples. This technique has not been
widely used for medical diagnostic purposes. This molecular technique was
essential for the overall success of the identification of organisms in the molecular
method. Without this technique 15 out of the 50 tissue samples would not have
provided readable DNA sequences for identification. The DGGE protocol has
several components that are important for DNA electrophoresis and visualization.
The method of pouring of the acrylamide solution was critical to ensure uniform
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movement and arrest of the PCR products. The Bio-Rad DCode system included a
calibrated wheel that was used. This was not an ideal method to use to prepare
generate the gradient gels. It was time consuming to setup and the gradient was
less consistent then the one obtained with a gravity gradient maker. The latter was
used for the analysis of the 50 tissue samples in this study.
The acrylamide and denaturing solution concentrations were critical to the
optimized migration of the PCR products. Several concentrations of both acrylamide
and denaturants were tested, but the best separation observed between the PCR
products was seen with a double gradient gel of acrylamide and denaturant. The
visualization of the DGGE gel bands also was a problem in the beginning of this
project. However, after performing experiments in which various amounts of DNA
were electrophoresed through the DGGE gel, it was determined that there was a
balance between over loading the gel, which produced smears, and loading too
little, which could hardly be seen. In addition, the use of GelRed to stain the DGGE
gel proved to be very useful. GelRed does not require a destaining step and is nontoxic, which is helpful when staining a large gel.
Several methods for DNA extraction from DGGE bands were explored. One
method was extraction of DNA using the QIAquick gel extraction kit (Qiagen)
modified for acrylamide gels based on the manufacturer’s recommendations. This
method gave very poor recovery of the DNA. About half of the DNA loaded into the
gel was lost. Secondly, a small piece of gel slice was placed directly into the PCR
tube to serve as the DNA template in a PCR reaction. This method only worked for
a few DGGE slices. It was not very consistent in producing a PCR product .Thirdly,
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the gel slice was cut into pieces and placed in a centrifuge tube with water and left
overnight. The DNA would then diffuse into the water, which served as the template
for PCR. This method was consistent and most DGGE slices gave a strong PCR
product. However, the question of whether all of the DNA was being released into
the water remained. The fourth method involved shredding the gel slice by bead
beating and leaving it overnight at 4°C. This method produced the most successful
template and all of the DNA present was most likely being released into the solution
to be used as a template for PCR amplification.
The sequencing and analysis of the DNA from the DGGE slices was the final
step in the molecular method. To obtain an optimal DNA sequence with no
background signal, it was important that primer dimers were not present in the
sequencing template. The use of linker primers was critical to the success of this
project because it allowed a DNA sequence of the entire PCR product to be
obtained (31). This was important because the PCR product size was not very large
(360 bp) and all the PCR product DNA sequence was needed to identify the species
with confidence.
The second goal of this study was to use the optimized 16S rDNA PCRDGGE method to analyze 50 tissue biopsy samples chosen randomly from our
collection. The molecular method was congruent for ten of the 17 (59%) culture
negative tissue samples. In seven of the 17 (41%) culture negative samples the
molecular method identified a bacterium. The molecular method was congruent with
the culture identification for seven of the 33 (21%) positive cultured tissue samples.
However, in eight of the 33 (24%) the molecular method identified more organisms.
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In 13 of the 15 (87%) polymicrobial cultured tissue samples the molecular method
identified at least one organism that was also identified by culture techniques.
Forty-seven out of the 50 (94%) tissue samples had anaerobic cultures
performed. Within those 47 tissue samples the molecular method found two tissue
samples to contain strict bacterial anaerobes that were not detect by culture
analysis. In one of the three tissue samples that did not have an anaerobic culture
performed, the molecular method found two strict anaerobe bacterial species. Even
though for the majority of the cases anaerobic cultures were taken the molecular
method was still able to identified additional strict anaerobes.
Eight tissue samples (1921, 2764, 93, 3514, 797, 65, 103, 864) in the 50
were collected when the patient was already on antibiotics. Specifically, for tissue
#1921 which was negative culture, samples were taken from a patient with a
positive culture of MRSA four days earlier, which may indicate that the antibiotic
was eradicating the infection but the molecular method was still able to detect
Staphylococcus aureus cells.
Another interesting case is tissue # 2764 which was found to be culture
negative, but had two cultures performed 12 and 14 weeks later. At 12 weeks the
culture analysis identified MRSA and Acinetobacter. At 14 weeks later the culture
analysis identified Acinetobacter, Group B Streptococcus, and Corynebacterium.
The molecular method was able to detect the Streptococcus sp. much earlier than
the culture method. Tissues #93 and #3514 were culture negative and had no
further evidence of infection after the course of antibiotics. Tissues #797, #65,
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#103, and #864 were found culture positive even though the patient was on
antibiotics at the time of tissue biopsy.
The differences in identification between the two methods could be due to
many reasons. The first and simplest reason is that each tissue sample tested by
the molecular method was not exactly the same as the sample that was used for the
culture method. All of the tissue samples used for the 16S rDNA PCR method were
the discarded tissue from the Medical Microbiology Lab and may not be a true
representative of the original tissue sample that was tested in their laboratory. This
potential problem could be resolved if the IRB protocol was modified to allow that
the biopsied tissue be mixed and split between the clinical laboratory and the
research laboratory immediately after the collection.
The second reason for a discrepancy between the culture and the molecular
results could be that the DNA extraction, PCR, or DGGE do not represent all
bacterial species in the tissue samples. Some kind of bias could be occurring in the
PCR amplification step of the molecular method. The experiment in which the PCR
amplification of three different templates in one reaction was performed seemed to
indicate that some PCR amplification bias may be occurring during this step. When
a low concentration of E. faecalis was added into a PCR amplification reaction with
templates that were 10 x and 100x more concentrated, it was difficult to observe the
E. faecalis PCR product in the DGGE gel. This PCR reaction represents the worst
case scenario that could possibly occur, which is having a DNA species that
represents only 1% of the DNA template. A bias in amplification of rare DNA
species is also supported by the fact that most species missed by the molecular
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method were usually noted as being rare or few in the culture results. This is the
case in tissue # 97; the molecular method detected Proteus mirabilis as the most
predominant bacterial species, but did not detect Corynebacterium and
Staphylococcus sp. which were described as ‘rare’ and ‘few’ respectively. A
possible solution for this problem could be using different conserved primers that
may be more efficient in amplification of the low percentage DNA species in a mixed
template PCR reaction. A second possible solution is performing a multiplex PCR
reaction which uses multiple primers in one PCR reaction. This type of PCR
amplification could be better in amplifying low percentage DNA species. A third
possible solution is to change the molecular method protocol of the second PCR
amplification step which adds the high GC region at the 5’ end, to use the
chromosomal DNA as template for the PCR reaction instead of the initial PCR
product as template. It is possible that a nested PCR reaction may not be very
efficient in amplifying rare DNA species and that returning to the chromosomal DNA
would be more efficient. The mixed template PCR amplification experiment may
indicate that an amplification bias against low percentage DNA species may exist.
However, additional experiment s should be done to understand this amplification
bias thoroughly.
A less likely reason for differences in identification between the two methods
could be insufficient separation between the PCR products of similar DNA species.
Some DNA species such as Pseudomonas and Staphylococcus aureus seem to
arrest their migration through the DGGE gel in very similar positions. Pseudomonas
and S. aureus were not found together by the molecular method, but they were
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identified together in one tissue sample by culture analysis. In cases where very
similar DNA PCR products or PCR products that migrate to a similar location in the
gel are present, a smaller DGGE gradient can be used to improve the separation.
Specifically to create greater separation between Pseudomonas and S. aureus a
45-60% denaturing solution gradient should be used. However, for most cases the
DGGE of the PCR products were found consistently in the same location. Almost all
bacterial species were consistently found is similar positions in the DGGE gel.
Some tissue samples were done multiple times at different time and consistently
showed the same pattern of DGGE DNA banding.
Overall, the DGGE analysis of 16S rDNA seems to be an alternative method
to identify bacteria not identified by culture analysis. This method does have
limitations for the identification of pathogens. The method requires specific
instrumentation and a person trained in these molecular techniques in order to be
successful. It relies on efficient amplification of all DNA species present and correct
separation of the PCR products in the DGGE gel, which has not been definitely
proven by this method. As a result this method may not be ideal for use in the
clinical microbiology laboratory for the general identification of pathogens. However,
in cases were no pathogen is cultured and the patient is not recovering with the
prescribed antibiotics, this method may provide some information that can aid in the
patient’s recovery.
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PERSPECTIVES
Several molecular techniques for bacterial identification have been
investigated by others in the field. These molecular techniques include antigen
recognition (43), PCR amplification of genes that are specific to the suspected
organism (14), microarrays (20), and 16S PCR amplification (40). However, these
investigations usually examine a small number of samples and do not compare the
molecular results to that of patient culture results. The goal of this project was to
develop a rapid, sensitive and unbiased molecular method to identify all possible
pathogens directly from infected tissue samples, without the need for culture. PCR
amplification of the 16S rRNA gene has been widely used because of the ability to
amplify thousands of possible bacteria present in the sample. After the PCR
amplification, sequence analysis is usually performed in order to identify the
organism. If several distinct PCR sequences are present in the PCR product direct
sequencing is not reliable. New sequencing technology may solve this problem.
Pyrosequencing is able to sequence multiple templates. However, currently this
technology is still expensive for mass clinical use as a method of pathogen
identification. In addition, pyrosequencing is limited to sequencing DNAs about 400
bp. If improvements are made in pyrosequencing or other types of single strand
sequencing methods and the cost of analysis is reduced this may be a good option
for pathogen identification.
Another molecular technique that may be a good option for rapid
identification of pathogens is mass spectrometry. This molecular technique is very
rapid and is becoming more commonly used. However, accurate identification of all
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species in polymicrobial infections using mass spectrometry is still under
discussion. Also a reference spectrum is required to obtain a definite identification
of the pathogen. At this point the database of reference spectrums is limited, but it is
growing rapidly. In the future this molecular technique may also be a suitable option
for molecular identification of all pathogens not just bacterial.
In the present time however a microarray may be the best option for a
molecular method to identify pathogens. The price of a microarray has decreased
and has become widely used and easier to construct. A tiled microarray of portions
of the entire 16S rRNA genes of hundreds of bacterial pathogens could be a rapid
and more standardized method for the identification of pathogens. Practically,
several different microarrays could be constructed, for the purposes of this study a
microarray with the most common and hard to culture musculoskeletal bacterial
pathogens would be used. However, if needed a microarray could be constructed
with pathogens associated with meningitis, cardiovascular infections or other types
of infections.
This investigation chose to develop a 16S rRNA gene PCR amplification
method for the identification of bacteria. To solve the problem of resolving mixed
DNA sequences in a PCR product, we chose to use a denaturing gradient gel
electrophoresis. This molecular technique separates DNA molecules into individual
species. DGGE has been used for monitoring bacterial populations in environmental
samples and has not been used extensively for pathogen identification. The use of
DGGE seemed promising as a rapid method for separating bacterial 16S rRNA
gene PCR products for sequence analysis. However, much like other 16S rRNA
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gene methods, the 16S rRNA gene PCR-DGGE method had problems. The results
of this study indicate that this method as currently optimized is not able to identify all
possible pathogens in a tissue sample. This molecular method may serve best to
identify pathogens in tissue samples that are culture negative.
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